Antibody responses after vaccination against equine influenza in Korea in 2016–2018
10.14405/kjvr.2019.59.3.151
- Author:
Min Su CHO
1
;
Ju Yeon LEE
;
Sang Kyu LEE
;
Jae Young SONG
;
Jienny LEE
;
Bang Hun HYUN
;
Soo Dong CHO
;
In Ohk OUH
Author Information
1. Animal and Plant Quarantine Agency, Gimcheon 39660, Korea. dvmoio@korea.kr
- Publication Type:Original Article
- Keywords:
horse;
equine influenza virus (EIV);
hemagglutination inhibition (HI);
antibody
- MeSH:
Antibody Formation;
Hemagglutination;
Horses;
Influenza A virus;
Influenza, Human;
Korea;
Mortality;
Orthomyxoviridae;
Vaccination;
Vaccines
- From:Korean Journal of Veterinary Research
2019;59(3):151-155
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Equine influenza (EI) is the main cause of respiratory illness in equines across the globe and is caused by equine influenza A virus (EIV-A), which has impacted the equine industry internationally because of the marginal mortality and high morbidity. In the present study, the immune responses after equine influenza vaccination were evaluated in 4,144 horses in Korea using the hemagglutination inhibition (HI) assay. The equine influenza virus (EIV), A/equine/South Africa/4/03 (H3N8), was used as the antigen in the HI assay. The mean seropositive rates were 89.2% (97.4% in 2016, 77.6% in 2017, and 92.4% in 2018). This paper highlights the advances in understanding the effects of vaccines and control strategies for mitigating the emerging menace by EIV.
